Gregorio, A. d., Häberle, L., Fasching, P. A., Müller, V., Schrader, I., Lorenz, R., . . . Janni, W. (2022). Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial. Friedrich-Alexander-Universität Erlangen-Nürnberg.
Chicago-Zitierstil (17. Ausg.)Gregorio, Amelie de, et al. Gemcitabine as Adjuvant Chemotherapy in Patients with High-risk Early Breast Cancer—results from the Randomized Phase III SUCCESS-A Trial. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.
MLA-Zitierstil (9. Ausg.)Gregorio, Amelie de, et al. Gemcitabine as Adjuvant Chemotherapy in Patients with High-risk Early Breast Cancer—results from the Randomized Phase III SUCCESS-A Trial. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.